Pfizer delivered a strong Q2 2025, beating revenue and EPS estimates, raising EPS guidance, and maintaining its attractive dividend yield above 7%. Product portfolio strength is evident, with growth in Primary Care, Specialty Care, and Oncology, but looming patent expiries and regulatory risks persist. Management's financial discipline is improving, with cost savings, debt management, and a focus on extracting value from recent M&A deals.

GlobalFoundries Inc. (NASDAQ:GFS ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants John C. Hollister - Chief Financial Officer Niels Anderskouv - President & COO Sam Franklin - Senior Vice President of Business Finance & Operations Timothy Graham Breen - CEO & Director Conference Call Participants Christopher Caso - Wolfe Research, LLC Christopher James Muse - Cantor Fitzgerald & Co., Research Division Harlan L.

DuPont de Nemours, Inc. (NYSE:DD ) Q2 2025 Earnings Call August 5, 2025 8:00 AM ET Company Participants Ann Giancristoforo - VP for Investor Relations Antonella B. Franzen - Senior VP & CFO Edward D.

Transocean Ltd. (NYSE:RIG ) Q2 2025 Earnings Conference Call August 5, 2025 9:00 AM ET Company Participants Alison Johnson - Director of Investor Relations Keelan I.

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Lineage, Inc. (NASDAQ: LINE) and certain of the Company's senior executives and directors for potential violations of the federal securities laws. If you invested in Lineage, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/lineage-inc-class-action-lawsuit.

Semrush Holdings, Inc. (NYSE:SEMR ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants Brian Mulroy - Chief Financial Officer Brinlea C. Johnson - Head of Investor Relations William R.

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between November 7, 2024 and July 8, 2025, both dates inclusive (the “Class Period”), of the important September 22, 2025 lead plaintiff deadline.

ARR offers a tempting 17% yield, but persistent book value erosion and a history of dividend cuts make me cautious. The hedging strategy supports current payouts, yet high leverage and rate/spread sensitivity expose ARR to significant downside risk. I prefer stable, lower-risk income; I need to see Fed rate cuts and book value stabilization before considering ARR for my portfolio.

Two Chinese nationals were arrested in California and charged with illegally shipping tens of millions of dollars' worth of AI chips to China, including Nvidia H100s, the U.S. Justice Department said Tuesday.

ONEOK, Inc. (NYSE:OKE ) Q2 2025 Earnings Conference Call August 5, 2025 11:00 AM ET Company Participants Megan Patterson - Corporate Participant Pierce H. Norton - President, CEO & Director Sheridan C.

Onity Group Inc. (NYSE:ONIT ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants Glen A. Messina - CEO, President & Chair of the Board Sean Bradley O'Neil - Executive VP & CFO Valerie C.

Dollar Tree Inc (NASDAQ:DLTR) stock nabbed a record high of $116.51 yesterday after an overdue price-target hike from Bernstein to $109 from $86.

Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.

Xometry, Inc. (NASDAQ:XMTR ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants James Miln - CFO & Principal Accounting Officer Randolph Brody Altschuler - Co-Founder, CEO & Director Shawn Christopher Milne - Vice President of Investor Relations Conference Call Participants Andrew M. Boone - Citizens JMP Securities, LLC, Research Division Brian Paul Drab - William Blair & Company L.L.C.

ADTRAN Holdings, Inc. (NASDAQ:ADTN ) Q2 2025 Earnings Conference Call August 5, 2025 10:30 AM ET Company Participants Peter Schuman - Corporate Participant Thomas R. Stanton - President, CEO & Chairman Timothy P.

After a good few years of disappointment languishing in the shadows of Big Oil rivals, executive departures, costly renewables forays, rumors of a takeover and an activist investor on its back, BP (LON: BP) has finally signalled to the market and its investors that a change might be on the horizon, backed up an improved quarterly performance.

CNBC's Andrew Ross Sorkin sits down with Brian Moynihan, Bank of America CEO, to discuss his reaction to President Trump's comments on 'Squawk Box' alleging that BofA rejected him as a customer, whether BofA is concerned about retribution, and much more.

Westlake Chemical Partners LP Common Units (NYSE:WLKP ) Q2 2025 Earnings Conference Call August 5, 2025 1:00 PM ET Company Participants Jean-Marc Gilson - President, CEO & Director Johnathan Stevan Zoeller - VP & Treasurer Mark Steven Bender - Executive VP, CFO & Director of Westlake Chemical Partners GP LLC Conference Call Participants Matthew Robert Lovseth Blair - Tudor, Pickering, Holt & Co. Securities, LLC, Research Division Operator Good afternoon. Thank you for standing by.

Blade Air Mobility sold its passenger/UAM division to Joby Aviation, shifting focus to medical organ transport and rebranding as Strata Critical Medical. The deal improves Blade's capital position but sacrifices the higher-growth air taxi opportunity, disappointing original investment expectations. Strata now controls 30% of the organ logistics market, with strong growth, solid profitability, and trades at an attractive valuation below 1x sales.

As artificial intelligence continues to reshape the tech landscape, major companies are ramping up investments to capitalize on this transformative trend.